A recent single-patient study has drawn attention after an older woman with advanced Alzheimer’s reportedly experienced temporary improvements in memory, communication, mobility, and daily functioning following the use of psilocybin-containing mushrooms. The case has sparked new conversations about psychedelic research, including interest around magic mushrooms Canada and the potential role of psilocybin in future medical studies.
While researchers emphasize that this is only one case and does not prove that psilocybin can reverse Alzheimer’s disease, the findings raise important questions about how psychedelic compounds may influence brain activity, neuroplasticity, and remaining cognitive abilities in people with dementia.
Table of Contents
What Happened in the Single-Patient Psilocybin Study?
A case study published in Frontiers in Neuroscience in May examined the effects of psilocybin-containing mushrooms on a Japanese-American woman in her 80s who had been living with advanced Alzheimer’s disease for approximately 10 years. The report attracted attention because the patient demonstrated noticeable functional improvements after receiving two doses of psilocybin, despite experiencing significant cognitive and physical limitations before the sessions.
According to the researchers, the woman had spent approximately five years communicating primarily through one-syllable words. Her condition had also affected her ability to swallow, control her bladder, move independently, and engage in spontaneous conversations.
How Was Psilocybin Given to the Woman?
During the first session, the woman received five grams of psilocybin-containing mushrooms known as the Enigma strain. The treatment was experimental because there is no established dosage or treatment guideline for using psilocybin in people with advanced Alzheimer’s disease.
- Initially — She experienced heavy sweating, a suspected increase in body temperature, and a prolonged period of deep sleep.
- Approximately 19 hours after taking the mushrooms — She began talking about personal memories without being prompted, and her conversations continued for several hours.
- One month later — The researchers conducted a second supervised session using a lower dose of three grams. This decision followed the improvements observed after the first session, including her continued ability to control her bladder.
- During the second session — She became more talkative and described a positive experience of surfing with her son on a peaceful island. Researchers also noticed improvements in her facial expressions, emotional responses, sense of humour, and walking ability.
Researchers did not report serious lasting side effects or delayed medical complications.
How Could Psilocybin Affect the Brain?
One possible explanation involves neuroplasticity, the brain’s ability to form and reorganize connections between nerve cells. Psilocybin may influence brain connectivity and encourage changes in how neural networks function. These effects could potentially help some remaining brain functions become more active, although this has not been established as a treatment for Alzheimer’s.
Another area of interest is how psilocybin affects communication between large-scale brain networks. There were changes in brain connectivity, including:
- Greater communication between certain brain regions
- Temporary changes in normal network organization
Researchers believe these effects may help explain some of the changes in perception, memory, and emotional processing reported after psilocybin use.
In the woman’s case, the improvements in memory recall, communication, mobility, emotional expression, and bladder control raised questions about whether psilocybin temporarily influenced brain networks responsible for these functions. Bladder control was particularly interesting because it involves several brain regions working together to recognize bodily signals and regulate responses.
However, scientists cannot yet explain exactly why these improvements occurred. The study did not include detailed brain scans, electrical brain activity measurements, or standardized cognitive tests that could confirm the underlying mechanisms.
| Access different psilocybin products and potencies at Zoomies Canada. We deliver anywhere in Canada. | Get some shrooms |
Other Possible Ways Psilocybin Could Influence Alzheimer’s Disease
Beyond its potential effects on neuroplasticity, researchers are exploring other ways psilocybin might influence brain function and processes associated with Alzheimer’s disease. These include reducing inflammation, supporting cognitive flexibility, and influencing emotional processing.
Although these mechanisms are still being investigated, findings from laboratory experiments, animal studies, and some human research offer interesting directions for future Alzheimer’s research.
The following table summarizes some of the proposed mechanisms:
| Potential mechanism | What research suggests |
|---|---|
| Anti-inflammatory effects | Reductions in inflammatory markers such as TNF-α, IL-1β, and IL-6. Changes in microglial activity, which may be relevant because brain inflammation is associated with Alzheimer’s progression. |
| Improved cognitive flexibility | Improvements in certain cognitive flexibility tasks following psilocybin administration. Some studies involving healthy adults and people with depression have also explored changes in cognitive and neural flexibility. |
| Emotional processing and regulation | Healthy volunteers and people with treatment-resistant depression have reported changes in emotional face recognition and activity in brain regions such as the amygdala. |
| Brain network connectivity | Changes in connectivity within and between large-scale brain networks, including the default mode network. These changes are being investigated for their possible relationship to cognitive and emotional function. |
Can Magic Mushrooms Help People With Alzheimer’s Disease?
Magic mushrooms may offer a potential area of research for Alzheimer’s disease, but there is currently not enough evidence to say that they can treat, reverse, or cure the condition.
The search for new approaches is especially important because there is currently no medication that can cure Alzheimer’s disease or completely stop its progression. Existing Alzheimer’s medications may help manage certain symptoms or temporarily support cognitive function in some patients, but they do not restore lost brain function or reverse the underlying disease process. Because of these limitations, scientists are exploring new strategies that may target different aspects of brain function.
For those interested in exploring the potential benefits of magic mushrooms, you can find a variety of strains and products in different forms at Zoomies Canada. Our selection of psilocybin-containing products comes in various potencies, flavours, and dosages. Both beginners and experienced users can find a product that suits their preferences. Order now.
Frequently Asked Questions
Could psilocybin help with non-memory symptoms of Alzheimer’s disease?
Beyond memory, psilocybin may influence other Alzheimer’s-related symptoms by affecting brain processes involved in neuroplasticity, emotional regulation, inflammation, and cognitive flexibility. Psilocybin may promote changes in brain connectivity, support neuronal plasticity, and influence pathways involved in mood and behaviour. These effects may be relevant to non-memory symptoms such as changes in communication, emotional responses, and social functioning.
Can psilocybin affect memories that appear to be lost in Alzheimer’s disease?
Psilocybin may have temporarily changed communication between surviving brain networks, making some remaining abilities more accessible. The brain may retain certain functional pathways even after significant decline, and psilocybin’s effects on brain connectivity and neuroplasticity may play a role.
Was talk therapy included in this psilocybin Alzheimer’s case study?
No. The case study did not include a structured talk therapy component like the preparation and integration sessions commonly used in modern psilocybin-assisted therapy. The intervention was exploratory and observational. It focuses on the effects of psilocybin administration and monitoring changes in the woman’s cognitive, physical, emotional, and social functioning.
The patient received supervised sessions involving psilocybin-containing mushrooms, but the report did not describe psychotherapy, guided emotional processing, or therapeutic counselling as part of the protocol. This differs from many psychedelic-assisted therapy studies, where psychological support is intentionally combined with psilocybin to help participants prepare for and process the experience.